Innovent Biologics(HK:1801)
HK$86.80-1.50 (-1.70%)
HK:1801
Innovent Biologics ownership
HK$86.80
At close:-1.50 (-1.70%)
Want to see HK:1801 full AI Analyst Report?
Innovent Biologics (1801) Ownership - Who Owns Innovent Biologics?
29 Followers
Innovent Biologics (1801) Ownership Overview
- 9.98% Mutual Funds
- 9.64% ETFs
- 80.39% Public Companies and Individual Investors
The ownership structure of Innovent Biologics (HK:1801) stock is a mix of institutional, retail, and individual investors. Approximately 19.61% of the company’s stock is owned by Institutional Investors, and 80.39% is owned by Public Companies and Individual Investors.
The ownership structure of Innovent Biologics (HK:1801) stock is a mix of institutional, retail, and individual investors. Approximately 19.61% of the company’s stock is owned by Institutional Investors, and 80.39% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ishares | 58,427,500 | Institution | 3.34% | 646,500,288 |
| Vanguard | 57,338,804 | Institution | 3.28% | 634,453,866 |
| Vanguard International Equity Index Funds | 28,098,608 | Institution | 1.61% | 310,911,098 |
| Vanguard Star Funds | 23,969,978 | Institution | 1.37% | 265,227,807 |
| Europacific Growth Fund | 23,895,500 | Institution | 1.37% | 264,403,708 |
| Eupac Fund | 20,115,000 | Institution | 1.15% | 222,572,475 |
| New World Fund Inc | 13,099,500 | Institution | 0.75% | 144,945,968 |
| Vanguard World Fund | 11,778,500 | Institution | 0.67% | 130,329,103 |
| Ubs | 11,686,900 | Institution | 0.67% | 129,315,549 |
| Amundi | 10,466,338 | Institution | 0.60% | 115,810,030 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard International Equity Index Funds | 28,098,608 | Institution | 1.61% | 310,911,098 |
| Vanguard Star Funds | 23,969,978 | Institution | 1.37% | 265,227,807 |
| Europacific Growth Fund | 23,895,500 | Institution | 1.37% | 264,403,708 |
| Eupac Fund | 20,115,000 | Institution | 1.15% | 222,572,475 |
| New World Fund Inc | 13,099,500 | Institution | 0.75% | 144,945,968 |
| Vanguard World Fund | 11,778,500 | Institution | 0.67% | 130,329,103 |
| Fidelity Investment Trust | 8,572,443 | Institution | 0.49% | 94,854,082 |
| Smallcap World Fund Inc | 6,938,500 | Institution | 0.40% | 76,774,503 |
| Fidelity Salem Street Trust | 6,865,497 | Institution | 0.39% | 75,966,724 |
| Hartford Mutual Funds Ii, Inc | 5,774,000 | Institution | 0.33% | 63,889,310 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Total International Stock ETF, VXUS ETF | 24,024,978 | Institution | 1.37% | 297,147,848 |
| Vanguard FTSE Emerging Markets ETF, VWO ETF | 22,941,820 | Institution | 1.31% | 283,751,038 |
| iShares Core MSCI Emerging Markets ETF, IEMG ETF | 16,451,000 | Institution | 0.94% | 180,848,021 |
| Avantis Emerging Markets Equity ETF, AVEM ETF | 6,208,500 | Institution | 0.36% | 69,359,900 |
| Vanguard FTSE All-World ex-US Index Fund, VEU ETF | 3,867,847 | Institution | 0.22% | 47,838,626 |
| iShares MSCI Emerging Markets ETF, EEM ETF | 3,633,000 | Institution | 0.21% | 39,938,050 |
| iShares MSCI China ETF, MCHI ETF | 3,500,000 | Institution | 0.20% | 38,475,963 |
| SPDR Portfolio Emerging Markets ETF, SPEM ETF | 2,095,000 | Institution | 0.12% | 23,580,433 |
| iShares Core MSCI Total International Stock ETF, IXUS ETF | 2,025,500 | Institution | 0.12% | 22,266,590 |
| Schwab Emerging Markets Equity ETF, SCHE ETF | 1,976,749 | Institution | 0.11% | 22,249,450 |
FAQ
What percentage of Innovent Biologics (HK:1801) stock is held by institutional investors?
According to the latest TipRanks data, approximately 19.61% of Innovent Biologics (HK:1801) stock is held by institutional investors: 9.98% by mutual funds and 9.64% by ETFs.
What percentage of Innovent Biologics (HK:1801) stock is held by retail investors?
According to the latest TipRanks data, approximately 80.39% of Innovent Biologics (HK:1801) stock is held by public companies and individual investors.
Who owns the most shares of Innovent Biologics (HK:1801)?
iShares owns the most shares of Innovent Biologics (HK:1801).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
